Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials

David Forster, JD, MA, CIP

Chief Compliance Officer, WCG

Articles by David Forster, JD, MA, CIP

Reviewing FDA’s Proposed IRB and Informed Consent Rule Changes

ByDavid Forster, JD, MA, CIP

January 26th 2023

21st Century Cures Act prompts FDA to harmonize regulations.

Latest Updated Articles

Trending on Applied Clinical Trials Online

Comparing OpenAI and Mistral on Clinical Trial Matching

Embedding AI Across the Clinical Operating Model: Q&A with Rajneesh Patil, Syneos Health

From Complexity to Endpoint Meaningfulness: Addressing Key Neuroscience Trial Challenges with eCOA

ACT Brief: Community Research Financing Gaps, Neuroscience Endpoint Data, and Teva’s Biosimilar Deal

From Signal to Action: Why Faster Trial Data Isn’t Producing Faster Decisions